Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Purpose
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Conditions
- Low Risk
- Papillary Thyroid Cancer
- Radiofrequency Ablation
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Criteria
Eligibility Criteria
1. Participants scheduled to undergo ultrasound-guided RFA for the following
conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and
recurrent PTC
2. Participant is over 18 years and is either not a surgical candidate or has declined
surgery.
3. Capable and willing to provide written informed consent
4. Participant has one of the following diagnoses:
- Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic
symptoms who are requesting treatment,
- Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
- Papillary thyroid carcinoma (PTC) without metastasis
- Locally recurrent thyroid cancer (< 2 cm).
Exclusion Criteria
1. Participants meeting any of the following criteria will be excluded:
2. Participants considered unsuitable for RFA by the treating physician
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Recruiting Locations
Houston, Texas 77030
More Details
- Status
- Recruiting
- Sponsor
- M.D. Anderson Cancer Center
Detailed Description
Primary Objectives • To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care Secondary Objectives - To establish the health-related quality of life among participants undergoing with ultrasound guided RFA. - To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA. - To assess adverse events rates following ultrasound guided RFA.